Baxter invests $100M to expand sterile fill/finish facility in Halle/Westfalen, Germany

Baxter International is investing approximately $100 million to expand its sterile fill/finish manufacturing facility in Halle/Westfalen, Germany, operated by BioPharma Solutions. The expansion will add a syringe filling line and additional vial capacity. Construction is expected to begin in 2022 and be completed in 2024.

“By making this investment, we are building on recent expansions to help ensure this facility can serve our partners at the highest level now and well into the future.”baxter.com

• 1 source
• baxter.comBaxter Announces $100 Million Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility | Baxter North AmericaNov 11, 2021

Summarized from public sources; check the original articles before acting on it.